Indefinite Delivery Contract W81K0224D0009

Award Date 9/29/24
Last Date to Order 9/28/29
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Ultimate Awardee
Revvity Inc.
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The key products and services being delivered under this indefinite delivery contract (IDC) awarded by the Defense Health Agency (DHA) are newborn screening testing services for the Brian Allgood Community Hospital (BAACH) and 121st Combat Support Hospital (CSH) in South Korea. The prime contractor, Revvity Omics Inc. (doing business as Perkinelmer Genetics), a subsidiary of Revvity Inc., will perform this work at its own facilities in Pittsburgh, Pennsylvania. The contract has a total ceiling...
The Blanket Purchase Agreement was awarded as a single-award contract by the Department of the Air Force United States Air Forces in Europe - Air Forces Africa to procure newborn metabolic screening test services for Spangdahlem Air Base in Germany. The potential value of the contract is $150,000. Orders may be placed through September 9, 2028. Perkinelmer Genetics, Inc. is the prime contractor, with Revvity Inc. identified as the parent company. The contract aims to provide newborn metabolic...
The Defense Health Agency awarded a single-award Indefinite Delivery Contract to the Washington State Department of Health to provide newborn screening services in support of military treatment facilities in Washington and Ohio. Task orders issued against the contract have potential values ranging from $0 to $663,308 and period of performances ending between April 2022 and April 2026. Under the contract, the Washington State Department of Health will leverage its expertise in public health...
The Department of the Army Medical Command awarded multiple blanket purchase agreements to Ambry Genetics Corporation for genetic testing services. The agreements have a potential value of $950,000 and require the contractor to provide genetic testing and variant confirmation services using whole genome sequencing and deletion/duplication analysis with next-generation sequencing technology. Performance is to be provided to Tripler Army Medical Center in Hawaii through September 7, 2025. The...
The federal contract IDV award is for clinical laboratory testing services to support U.S. military healthcare operations in South Korea. The prime contractor is Seoul Clinical Laboratories, a for-profit research institute in South Korea that provides a wide range of medical laboratory services, including COVID-19 testing, to U.S. Department of Defense (DoD) agencies. The contract is a single-award indefinite delivery vehicle (IDV) valued at $547,695.69 awarded by the Defense Health Agency, with...
The Department of the Army Medical Command awarded multiple blanket purchase agreements to PreventionGenetics LLC for genetic testing services. The agreements have a potential value of $950,000 and require the contractor to provide genetic testing and variant confirmation services including whole genome sequencing and deletion/duplication analysis using next generation sequencing technology. Services are to be provided to Tripler Army Medical Center in Hawaii as detailed in the performance...
The Department of the Army Medical Command awarded multiple blanket purchase agreements to Laboratory Corporation of America for genetic testing services. The agreements have a potential value of $950,000 and require the contractor to provide genetic testing and variant confirmation services using whole genome sequencing and deletion/duplication analysis with next-generation sequencing technology. Services will be provided to Tripler Army Medical Center in Hawaii through September 7, 2025. The...
The U.S. Department of the Air Force, Pacific Air Forces (PACAF), awarded a multiple-award Blanket Purchase Agreement (BPA) contract to Seoul Clinical Laboratories, a for-profit research institute located in South Korea. The $250,000 BPA provides clinical laboratory testing and diagnostic services, including COVID-19 testing, general blood work, and pathology testing, to support U.S. military healthcare operations in South Korea. The contract has a period of performance through February 2026 and...
The Department of the Army Medical Command has awarded Neogenomics Laboratories, Inc., a for-profit cancer diagnostics laboratory, a 5-year Blanket Purchase Agreement (BPA) to provide NEOTYPE SOLID TUMOR TESTING AND REPEAT FISH TESTING at Tripler Army Medical Center in Hawaii. The BPA has a potential value of $1,000,000.00 and covers the period from April 1, 2019 to March 11, 2024. Through this single-award IDV, Neogenomics will furnish specialized cancer testing and diagnostic services,...
The Defense Health Agency awarded a single-award Indefinite Delivery Contract to the Virginia Department of General Services for newborn screening services in support of Naval Medical Center Portsmouth in Virginia. Task orders issued against the contract total $3.036M and provide newborn screening testing, case management, and specialty physician consultation through April 2026 at various locations in Portsmouth, Virginia. The originating solicitation sought capability statements from seven...
  • W81K0224D0009
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Department of Defense's Defense Health Agency has awarded an indefinite delivery contract (IDC) to Revvity Omics Inc., doing business as Perkinelmer Genetics, to provide newborn screening testing services for the Brian D. Allgood Army Community Hospital in South Korea. The single-award IDC has a $301,668 ceiling value and a period of performance from September 29, 2024 through September 28, 2029, with a base year plus four one-year option periods.

Under this contract, Perkinelmer Genetics, a for-profit medical testing services company, will perform newborn screening tests to detect conditions such as galactosemia, hypothyroidism, sickle cell disease, and cystic fibrosis. The testing will support the military healthcare system and early intervention for life-threatening conditions in infants. Perkinelmer Genetics has extensive experience providing these specialized services to federal agencies, including previous contracts with the Department of Defense. The contract does not utilize any small business set-asides, and offerors must obtain the necessary business licenses to operate in South Korea under the U.S.-Korea Status of Forces Agreement.

Generated 12/4/24, 9:04 AM